On Tuesday, Shares of Spirit Realty Capital, Inc (New) (NYSE:SRC), lost -0.41% to $9.69. 3.05 million shares of the company were exchanged.
Spirit Realty Capital, Inc. (SRC) a premier net lease real estate investment trust (REIT) that invests in single-tenant, operationally essential real estate, declared that on Thursday, November 5, 2015, before the opening of the Stock Market, Spirit plans to release its financial and operating results for the three and nine months ended September 30, 2015.
Spirit Realty Capital, Inc is a publicly traded real estate investment trust. The firm primarily acquires across the United States single tenant operationally essential real estate, which refers to generally free-standing, commercial real estate facilities where tenants conduct retail, service or distribution activities that are essential to the generation of their sales and profits.
Shares of Celgene Corporation (NASDAQ:CELG), declined -3.26% to $113.77, during its last trading session.
Celgene International Sàrl, a wholly owned partner of Celgene Corporation (CELG), declared that results from its ongoing phase III LIBERATE™ trial evaluating Otezla® (apremilast), the Company’s oral, selective inhibitor of phosphodiesterase 4 (PDE4), in patients with moderate to severe plaque psoriasis were presented as a late-breaker at the 24th European Academy of Dermatology and Venereology (EADV) Congress in Copenhagen, Denmark, October 7-11, 2015.
The LIBERATE study evaluated the clinical efficacy and safety of either oral OTEZLA 30 mg twice daily or weekly subcutaneous (SC) etanercept 50 mg contrast with placebo at week 16 in 250 patients who had no preceding exposure to a biological therapy. It also examined the relative safety of a switch from etanercept to OTEZLA after week 16 during an open label extension phase. Primary findings were formerly presented at the 73rd Annual Meeting of the American Academy of Dermatology (AAD) in San Francisco, California. LIBERATE was not designed or powered to directly compare OTEZLA to etanercept.
As shown at AAD, at week 16, 40 percent (33/83) of patients receiving OTEZLA 30 mg twice daily demonstrated statistically noteworthy and clinically meaningful improvements contrast with 12 percent (10/84) of patients on placebo in the primary endpoint, Psoriasis Area and Severity Index (PASI)-75 response (P<0.0001). Statistical significance was also achieved for patients receiving weekly injections of etanercept 50 mg contrast with placebo [48 percent (n=40/83) vs. 12 percent (n=10/84), respectively, P<0.0001].
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally.
Finally, Shares of Union Pacific Corporation (NYSE:UNP), ended its last trade with -1.54% loss, and closed at $93.79.
It sounds simple. When railroad crossing arms are down or the warning lights are flashing, drivers and pedestrians must wait for the passing train. But last year, Federal Railroad Administration statistics reveal 915 people nationwide were killed or injured trespassing on railroad property.
Union Pacific Railroad this week launched a new campaign exclusively on social media, urging drivers and pedestrians to think about their personal safety first and wait at grade crossings. New videos depict different scenarios in which a jogger, young couple and father and son are stopped, waiting for a train to pass. When the arms lift, each proceeds safely toward a spectacular future.
This is Union Pacific’s second safety campaign launched exclusively on social media this year. The first addressed high school photography on railroad tracks.
Union Pacific Corporation, through its partner, Union Pacific Railroad Company, operates railroads in the United States. The company offers freight transportation services for agricultural products, counting grains, commodities produced from grains, and food and beverage products; automotive products, such as finished vehicles and automotive parts; and chemicals comprising of industrial chemicals, plastics, crude oil, liquid petroleum gases, fertilizers, soda ash, sodium products, and phosphorus rock and sulfur products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
